Furthermore, we found that STAT4 mRNA levels predicted an improved OS in grade III and stage III/IV but not grade I/II and stage I/II ovarian cancer patients, suggesting that this gene is a favorable prognosis indicator especially for late stage and poor differentiation in ovarian cancer patients. Here, STAT4 is linked to ovarian carcinoma.